Paroxetine 10mg/5ml Oral Suspension

Manufacturer ANI PHARMACEUTICALS Active Ingredient Paroxetine Suspension(pa ROKS e teen) Pronunciation pa ROKS e teen
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat obsessive-compulsive problems.It is used to treat panic attacks.It is used to treat anxiety.It is used to treat post-traumatic stress. It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Selective Serotonin Reuptake Inhibitor (SSRI)
🤰
Pregnancy Category
Category D
✅
FDA Approved
Dec 1992
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Paroxetine is a medication used to treat depression, anxiety disorders, obsessive-compulsive disorder, and panic attacks. It works by helping to restore the balance of a natural substance (serotonin) in the brain, which can improve mood, sleep, appetite, and energy levels, and decrease nervousness and unwanted thoughts.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.

Before using the liquid form of this medication, shake the bottle well. Measure your dose carefully using the measuring device provided with the medication. If a measuring device is not included, ask your pharmacist for one. Unless your doctor advises otherwise, take your medication in the morning.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist. If you have questions about disposing of your medication, ask your pharmacist. You may also want to check if there are any drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take exactly as prescribed, usually once daily in the morning, with or without food.
  • Do not stop taking paroxetine suddenly, as this can cause withdrawal symptoms. Your doctor will guide you on how to slowly reduce the dose if needed.
  • Avoid alcohol while taking paroxetine, as it can worsen side effects like drowsiness.
  • Be cautious when driving or operating machinery until you know how this medication affects you.
  • Report any unusual changes in mood or behavior, especially suicidal thoughts, to your doctor immediately.
  • Inform your doctor and pharmacist about all other medications, supplements, and herbal products you are taking to avoid harmful interactions.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For Major Depressive Disorder (MDD), typically 20 mg once daily, usually in the morning. For Panic Disorder, 10 mg once daily, titrate to 40 mg once daily.
Dose Range: 10 - 60 mg

Condition-Specific Dosing:

Major Depressive Disorder (MDD): Initial: 20 mg/day; Max: 50 mg/day
Obsessive-Compulsive Disorder (OCD): Initial: 20 mg/day; Max: 60 mg/day
Panic Disorder: Initial: 10 mg/day; Max: 60 mg/day
Social Anxiety Disorder (SAD): Initial: 20 mg/day; Max: 50 mg/day
Generalized Anxiety Disorder (GAD): Initial: 20 mg/day; Max: 50 mg/day
Post-Traumatic Stress Disorder (PTSD): Initial: 20 mg/day; Max: 50 mg/day
Premenstrual Dysphoric Disorder (PMDD): Initial: 12.5 mg/day (CR) or 20 mg/day (IR) daily or luteal phase dosing; Max: 25 mg/day (CR) or 20 mg/day (IR)
Vasomotor Symptoms of Menopause: Initial: 7.5 mg/day (CR); Max: 7.5 mg/day (CR)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not generally recommended due to Black Box Warning for suicidality; limited data for OCD (7-17 years): Initial 10 mg/day, titrate to 20-30 mg/day. Max 50 mg/day.
Adolescent: Not generally recommended due to Black Box Warning for suicidality; limited data for OCD (7-17 years): Initial 10 mg/day, titrate to 20-30 mg/day. Max 50 mg/day.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed
Moderate: Initial dose 10 mg/day, titrate cautiously. Max 40 mg/day.
Severe: Initial dose 10 mg/day, titrate cautiously. Max 40 mg/day.
Dialysis: Initial dose 10 mg/day, titrate cautiously. Max 40 mg/day. Paroxetine is not significantly removed by dialysis.

Hepatic Impairment:

Mild: Initial dose 10 mg/day, titrate cautiously. Max 40 mg/day.
Moderate: Initial dose 10 mg/day, titrate cautiously. Max 40 mg/day.
Severe: Initial dose 10 mg/day, titrate cautiously. Max 40 mg/day.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Paroxetine is a potent and highly selective inhibitor of serotonin (5-hydroxytryptamine; 5-HT) reuptake in the central nervous system (CNS). This inhibition leads to an increase in the concentration of serotonin in the synaptic cleft, enhancing serotonergic neurotransmission. It has weak effects on norepinephrine and dopamine neuronal reuptake. It also has weak anticholinergic effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 60-70% (due to first-pass metabolism)
Tmax: Approximately 5.2 hours (oral suspension)
FoodEffect: Food does not significantly affect absorption, but may decrease peak plasma concentrations and delay Tmax. Can be taken with or without food.

Distribution:

Vd: Approximately 2.8 L/kg
ProteinBinding: Approximately 95%
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 21 hours (range 7-65 hours), can be longer in some individuals due to saturable metabolism.
Clearance: Variable, decreases with increasing dose due to saturable metabolism.
ExcretionRoute: Approximately 64% via urine (2% as unchanged drug, 62% as metabolites); approximately 36% via feces (30% as metabolites, 6% as unchanged drug).
Unchanged: Approximately 2% (urine), 6% (feces)
âąī¸

Pharmacodynamics

OnsetOfAction: Initial symptomatic improvement may be seen within 1-2 weeks; full therapeutic effects may take 4-6 weeks or longer.
PeakEffect: Typically 4-6 weeks for full antidepressant/anxiolytic effect.
DurationOfAction: Due to its half-life, effects persist for approximately 24 hours, allowing once-daily dosing. Withdrawal symptoms can occur rapidly if discontinued abruptly.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of paroxetine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults older than 24 years; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 years and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Difficulty focusing or memory problems
+ Feeling confused or weak
+ Seizures or changes in balance
Signs of infection, such as:
+ Fever or chills
+ Severe sore throat, ear or sinus pain, or cough
+ Increased sputum production or a change in sputum color
+ Pain while urinating or mouth sores
+ A wound that will not heal
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Severe dizziness or fainting
Bone pain
Seizures
Significant weight loss
Abnormal burning, numbness, or tingling sensations
Painful or prolonged erections (lasting more than 4 hours)
Sexual problems, including decreased interest in sex, difficulty having an orgasm, ejaculation problems, or trouble getting or maintaining an erection

Serotonin Syndrome: A Rare but Serious Condition

There is a risk of developing serotonin syndrome, a potentially life-threatening condition, especially when taking certain other medications. Seek medical help immediately if you experience:

Agitation
Changes in balance or coordination
Confusion
Hallucinations
Fever
Rapid or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, stomach upset, or vomiting
Severe headache

Other Possible Side Effects

While many people may not experience any side effects or only mild ones, it is essential to be aware of the following potential side effects:

Dizziness, drowsiness, fatigue, or weakness
Nervousness or excitability
Headache
Constipation, diarrhea, stomach pain, nausea, vomiting, or decreased appetite
Gas
Dry mouth
Sleep disturbances
Shakiness
Yawning
Back pain
* Sweating

If you are concerned about any side effects or if they persist or worsen, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • Thoughts of harming yourself or others
  • New or severe agitation, restlessness, panic attacks, insomnia
  • Unusual changes in behavior (e.g., extreme excitement, irritability, aggression)
  • Symptoms of serotonin syndrome: fast heartbeat, hallucinations, fever, sweating, shivering, muscle stiffness or twitching, loss of coordination, nausea, vomiting, diarrhea.
  • Unusual bleeding or bruising
  • Severe skin rash or allergic reaction
  • Eye pain, vision changes, or swelling around the eye (signs of angle-closure glaucoma)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
If you have been diagnosed with narrow-angle glaucoma.
If you are currently taking or have recently taken any of the following medications: Linezolid, methylene blue, pimozide, or thioridazine.
If you have taken certain medications for depression or Parkinson's disease within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may increase the risk of very high blood pressure.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to inform your doctor and pharmacist about all the medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you have. Before starting, stopping, or changing the dose of any medication, consult with your doctor to confirm that it is safe to do so in conjunction with this medication.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

When starting this medication, be cautious and avoid driving or engaging in activities that require alertness until you understand how it affects you.

To minimize the risk of side effects, do not abruptly stop taking this medication without consulting your doctor. If you need to discontinue use, your doctor will guide you on how to gradually stop taking it.

While taking this medication, it is recommended that you avoid consuming alcohol. Additionally, before using marijuana, other forms of cannabis, or prescription and over-the-counter drugs that may cause drowsiness, consult with your doctor.

It may take several weeks to experience the full effects of this medication.

There are potential risks associated with this medication, including an increased chance of fractures. Discuss this risk with your doctor.

This medication may also increase the risk of bleeding, which can be life-threatening in some cases. Consult with your doctor about this risk.

Some individuals may have a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness around the eye, contact your doctor immediately.

Low sodium levels, which can be life-threatening and lead to seizures, loss of consciousness, breathing difficulties, or death, are a possible side effect of this medication.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

In children and teenagers, this medication may affect growth. Regular growth checks may be necessary, so discuss this with your doctor.

There is a potential impact on fertility, and it is unclear if this effect is reversible.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. Taking this medication during the first trimester may increase the risk of birth defects, particularly heart defects, in the unborn baby. Use during the third trimester may increase the risk of postpartum bleeding and potentially cause health problems in the newborn. If you are breastfeeding, discuss the potential risks to your baby with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Drowsiness
  • Nausea
  • Vomiting
  • Tremor
  • Tachycardia (fast heart rate)
  • Agitation
  • Dizziness
  • Dilated pupils
  • Serotonin syndrome (severe cases)

What to Do:

Seek immediate medical attention or call Poison Control at 1-800-222-1222. Bring the medication bottle with you.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) (risk of serotonin syndrome)
  • Pimozide (risk of QT prolongation)
  • Thioridazine (risk of QT prolongation and ventricular arrhythmias)
  • Linezolid (MAOI activity)
  • Methylene blue (MAOI activity)
🔴

Major Interactions

  • Other serotonergic drugs (e.g., triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort) - increased risk of serotonin syndrome.
  • Drugs metabolized by CYP2D6 (e.g., flecainide, propafenone, metoprolol, atomoxetine, risperidone, tamoxifen) - increased plasma concentrations of these drugs.
  • Warfarin and other anticoagulants/antiplatelets (e.g., NSAIDs, aspirin) - increased risk of bleeding.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, some antipsychotics, macrolide antibiotics) - theoretical increased risk of QT prolongation.
  • Phenytoin, Phenobarbital, Carbamazepine - decreased paroxetine levels; paroxetine may increase phenytoin/carbamazepine levels.
🟡

Moderate Interactions

  • Cimetidine - increases paroxetine levels.
  • Fosamprenavir/Ritonavir - decreases paroxetine levels.
  • Theophylline - paroxetine may increase theophylline levels.
  • Digoxin - paroxetine may increase digoxin levels.
  • Alcohol - concurrent use not recommended due to potential for increased CNS depression.
đŸŸĸ

Minor Interactions

  • Not specifically categorized as minor, but caution with any CNS depressants.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Psychiatric evaluation (diagnosis, symptom severity)

Rationale: To establish baseline and guide treatment, assess for suicidality.

Timing: Prior to initiation

Renal and Hepatic function tests (e.g., SCr, BUN, ALT, AST)

Rationale: To assess organ function for appropriate dosing adjustments.

Timing: Prior to initiation

Electrolytes (especially Sodium)

Rationale: To establish baseline, as hyponatremia can occur.

Timing: Prior to initiation

Medication history (including OTCs, herbals)

Rationale: To identify potential drug-drug interactions, especially serotonergic agents or CYP2D6 substrates/inhibitors.

Timing: Prior to initiation

📊

Routine Monitoring

Clinical response and symptom severity (e.g., HAM-D, GAD-7, PHQ-9)

Frequency: Weekly for first 4-6 weeks, then monthly or as clinically indicated.

Target: Reduction in symptom scores, improved functional status.

Action Threshold: Lack of improvement after adequate trial, worsening symptoms, or emergence of new symptoms (e.g., suicidality).

Adverse effects (e.g., GI upset, sexual dysfunction, insomnia/somnolence, weight changes, agitation, anxiety)

Frequency: Regularly, especially during dose titration and initial weeks.

Target: Tolerable side effect profile.

Action Threshold: Intolerable side effects, emergence of serotonin syndrome symptoms, or signs of activation/mania.

Blood pressure and heart rate

Frequency: Periodically, especially in patients with cardiovascular risk factors.

Target: Within normal limits.

Action Threshold: Significant changes or arrhythmias (though less common with paroxetine).

Sodium levels

Frequency: Periodically, especially in elderly, those on diuretics, or with volume depletion.

Target: 135-145 mEq/L

Action Threshold: Hyponatremia (<135 mEq/L), especially if symptomatic.

Weight

Frequency: Periodically

Target: Stable or within healthy range.

Action Threshold: Significant weight gain or loss.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence of suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, hostility, impulsivity)
  • New or worsening anxiety
  • Panic attacks
  • Insomnia
  • Restlessness
  • Mania or hypomania
  • Serotonin syndrome symptoms (e.g., agitation, hallucinations, rapid heart beat, fever, sweating, shivering, muscle rigidity, twitching, incoordination, nausea, vomiting, diarrhea)
  • Abnormal bleeding or bruising
  • Symptoms of hyponatremia (e.g., headache, confusion, weakness, seizures)

Special Patient Groups

🤰

Pregnancy

Category D. Use during pregnancy, especially the first trimester, has been associated with an increased risk of cardiovascular malformations (e.g., atrial and ventricular septal defects). Third-trimester exposure has been associated with persistent pulmonary hypertension of the newborn (PPHN) and neonatal withdrawal syndrome. Use only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Increased risk of cardiovascular malformations (e.g., septal defects).
Second Trimester: Less data on specific malformations, but continued exposure.
Third Trimester: Risk of PPHN and neonatal withdrawal syndrome (e.g., respiratory distress, feeding difficulties, jitteriness, seizures).
🤱

Lactation

L3 (Moderate Concern). Paroxetine is excreted into breast milk. While levels in breast milk are generally low, some infants may experience adverse effects (e.g., sedation, poor feeding, weight loss). Monitor breastfed infants for adverse effects. Consider alternative agents with lower infant exposure or risk, or weigh benefits vs. risks.

Infant Risk: Low to moderate risk of adverse effects. Monitor for sedation, irritability, poor feeding, and weight changes.
đŸ‘ļ

Pediatric Use

Generally not recommended for children and adolescents due to the Black Box Warning regarding increased risk of suicidal thoughts and behaviors. Limited use in specific conditions like OCD where benefits may outweigh risks, with close monitoring.

👴

Geriatric Use

Use with caution. Elderly patients may be more sensitive to the effects of paroxetine, including hyponatremia and CNS effects (e.g., dizziness, falls). Lower initial doses and slower titration are recommended. Max dose typically 40 mg/day.

Clinical Information

💎

Clinical Pearls

  • Paroxetine has a relatively short half-life among SSRIs, making it more prone to withdrawal symptoms if discontinued abruptly. Tapering is crucial.
  • It is a potent inhibitor of CYP2D6, which is important for drug-drug interaction assessment, especially with drugs like tamoxifen, metoprolol, and tricyclic antidepressants.
  • Paroxetine has mild anticholinergic effects, which can contribute to side effects like constipation or dry mouth, and may be a consideration in elderly patients.
  • Consider the controlled-release (CR) formulation for patients experiencing significant nausea or other GI side effects with the immediate-release (IR) form.
  • Sexual dysfunction (e.g., decreased libido, anorgasmia) is a common and often bothersome side effect that can impact adherence. Discuss this with patients proactively.
  • Weight gain can occur with long-term use of paroxetine.
🔄

Alternative Therapies

  • Other SSRIs (e.g., Fluoxetine, Sertraline, Citalopram, Escitalopram, Fluvoxamine)
  • SNRIs (e.g., Venlafaxine, Duloxetine, Desvenlafaxine)
  • Atypical antidepressants (e.g., Bupropion, Mirtazapine, Trazodone, Vortioxetine, Vilazodone)
  • Tricyclic Antidepressants (TCAs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
  • Electroconvulsive Therapy (ECT) for severe depression
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 300ml (10mg/5ml)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a patient fact sheet that provides crucial information. It is vital to read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the quantity, and the time it occurred.